Insperity, Inc. (NSP)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Insperity, Inc. To Contact The Firm 

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Insperity, Inc. (“Insperity” or the “Company”) (NYSE:NSP) of the September 21, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. 

If you invested in Insperity stock or options between February 11, 2019 and February 11, 2020 and would like to discuss your legal rights, please fill out the form below. There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to  

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Insperity common stock between February 11, 2019 and February 11, 2020 (the “Class Period”).  The case, Building Trades Pension Fund of Western Pennsylvania v. Insperity, Inc. et al., No. 1:20-cv-05635 was filed on July 21, 2020.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company had failed to negotiate appropriate rates with its customers for employee benefit plans and did not adequately disclose the risk of large medical claims from these plans; (2) Insperity was experiencing an adverse trend of large medical claims; (3) as a mitigating measure, the Company would be forced to increase the cost of its employee benefit plans, causing stunted customer growth and reduced customer retention; and (4) the foregoing issues were reasonably likely to, and would, materially impact Insperity’s financial results.

Specifically, on July 29, 2019, Insperity released its second quarter 2019 financial results. Despite delivering year-over-year growth and meeting analysts’ estimates, the Company offered disappointing third quarter 2019 guidance and reduced its full-year 2019 guidance. Further, Defendants revealed that in the second quarter 2019, Insperity had experienced an increase in large medical claim costs, which Defendants described as an anomaly which would not impact projected cost benefit trends. 

On this news, the Company's stock price fell from $144.63 per share on July 26, 2019 to $108.89 per share on July 29, 2019: a $35.74 or 24.71% drop.

Second, on November 4, 2019, Insperity released its third quarter 2019 financial results, which substantially missed analysts’ estimates and were materially down year-overyear. In addition, Insperity materially reduced its full-year 2019 guidance. Defendants attributed these results to continued large medical claim costs, which they again attempted to describe as a mere anomaly to assuage investor concern. 

On this news, the Company's stock price fell from $107.67 per share on November 1, 2019 to $71.38 per share on November 4, 2019: a $36.29 or 33.70% drop.

Finally, on February 11, 2020, after the close of trading, Insperity released its fourth quarter and full-year 2019 financial results. While the Company’s results were in line with its (repeatedly downgraded) financial forecasts, Insperity revealed that large medical claims had again impacted the Company by significantly increasing operational costs. Further, the Company stated that it had restructured its contract with UnitedHealthcare to no longer have financial responsibility for any medical claims over $1 million. Finally, Insperity offered disappointingly bearish guidance for the first quarter and full-year 2020. Analysts immediately lowered their views on Insperity stock. For example, analysts at Baird cut their rating from “Outperform” to “Neutral” stating that “after three quarters, rising jumbo claims appear to be a trend, not aberrational.” 

On this news, the Company's stock price fell from $89.08 per share on February 11, 2020 to $71.64 per share on February 12, 2020: a $17.44 or 19.38% drop.

Contact us

Insperity, Inc. (NSP)

Loading captcha, please wait...

* The submission of this form does not create an attorney-client relationship.


Filed on 07/22/2020


Lead Plaintiff Deadline 09/21/2020


685 Third Avenue 26th Floor

10017 New York, New York

Phone (212) 983-9330

Fax (212) 983-9331


Richard W. Gonnello Phone (212) 983-9330 Fax (212) 983-9331

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885


3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612


3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania